We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
–
AUM
$52.6M
AUM Growth
-$5.52M
Cap. Flow
-$9.39M
Cap. Flow %
-17.88%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NTLA icon
Intellia Therapeutics
NTLA
+$9.39M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
1
Intellia Therapeutics
NTLA
$1.48B
$52.6M 100%
3,729,788
-700,000
-16% -$9.39M

Similar funds

EEPIS
Evolution Equity Partners II SARL Luxembourg $11.8M AUM 63.6% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
MM
Malka Meyer $8.77M AUM 64.77% 1-Year Est. Return

Atlas Venture Associates IX's Q1 2017 Portfolio in Review

As of Q1 2017, Atlas Venture Associates IX held 1 position worth $52.6M, down 9.5% from $58.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Associates IX withdrew a net $9.39M in Q1 2017, reducing 1 holding. Its largest reduction was Intellia Therapeutics, cutting an estimated $9.39M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Atlas Venture Associates IX's biggest Q1 2017 reduction was Intellia Therapeutics, cutting an estimated $9.39M.
  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $52.6M portfolio in Q1 2017.
  • Atlas Venture Associates IX opened 0 new positions and closed 0 in Q1 2017.
  • Atlas Venture Associates IX's portfolio value fell 9.5% quarter-over-quarter to $52.6M.

Based on Atlas Venture Associates IX's 13F filing for Q1 2017, filed 11 May 2017.